| Name |
|---|
MAFD3 GeneMajor affective disorder 3, early onset |
GLC1N Geneglaucoma 1, open angle, N (juvenile-onset) |
GLC1L Geneglaucoma 1, open angle, L (adult-onset) |
GLC1M Geneglaucoma 1, open angle, M (juvenile-onset) |
GLC1J Geneglaucoma 1, open angle, J (juvenile-onset) |
GLC1K Geneglaucoma 1, open angle, K (juvenile-onset) |
GLC1H Geneglaucoma 1, open angle, H (adult-onset) |
GLC1D Geneglaucoma 1, open angle, D (adult-onset) |
GLC1B Geneglaucoma 1, open angle, B (adult-onset) |
BRCA1 Genebreast cancer 1, early onset This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020] |
BRCA2 Genebreast cancer 2, early onset Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020] |
CCAL1 Genechondrocalcinosis 1 (calcium pyrophosphate-deposition disease, early onset osteoarthritis) |
CTPL1 Genecataract, pulverulent (autosomal recessive, early-onset) |
COPD GenePulmonary disease, chronic obstructive, severe early-onset |
NIDDM4 GeneDiabetes mellitus, noninsulin-dependent |
NIDDM2 Genenon-insulin-dependent diabetes mellitus (common, type 2) 2 |
NIDDM3 GeneNoninsulin-dependent diabetes mellitus 3 |
NIDDM1 Genenon-insulin-dependent diabetes mellitus (common, type 2) 1 |
IDDM18 Geneinsulin-dependent diabetes mellitus 18 |
IDDM15 Geneinsulin-dependent diabetes mellitus 15 |
IDDM13 Geneinsulin-dependent diabetes mellitus 13 |
IDDM11 Geneinsulin-dependent diabetes mellitus 11 |
IDDM24 GeneDiabetes mellitus, insulin-dependent, 24 |
IDDM23 GeneDiabetes mellitus, insulin-dependent, 23 |
IDDM17 Geneinsulin-dependent diabetes mellitus 17 |
IDDM16 Geneinsulin-dependent diabetes mellitus 16 |
IDDM14 Geneinsulin-dependent diabetes mellitus 14 |
RRAD GeneRas-related associated with diabetes Predicted to enable GTP binding activity and calcium channel regulator activity. Predicted to be involved in small GTPase-mediated signal transduction. Predicted to be located in T-tubule. Predicted to be active in plasma membrane. Implicated in type 2 diabetes mellitus. Biomarker of congestive heart failure. [provided by Alliance of Genome Resources, Mar 2025] |
TNDM Genediabetes mellitus, transient neonatal Transient neonatal diabetes mellitus is associated with overexpression of a region containing the PLAGL1 and HYMAI genes on chromosome 6q24. These genes are normally imprinted and expressed only from the paternal allele. Imprinting is regulated by differential methylation of a CpG island in this region. [provided by RefSeq, May 2015] |
IDDMX GeneDiabetes mellitus, insulin-dependent, X-linked, susceptibility to |
IDDM7 Geneinsulin-dependent diabetes mellitus 7 |
IDDM6 Geneinsulin-dependent diabetes mellitus 6 |
IDDM4 Geneinsulin-dependent diabetes mellitus 4 |
IDDM3 Geneinsulin-dependent diabetes mellitus 3 |
IDDM9 Geneinsulin-dependent diabetes mellitus 9 |
IDDM8 Geneinsulin-dependent diabetes mellitus 8 |